The Arab Drug Company (EGX:ADCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
173.17
0.00 (0.00%)
At close: Jun 4, 2025

The Arab Drug Company Income Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Operating Revenue
1,024784.65630.1503.79537.05520.8
Upgrade
Other Revenue
2.270.883.641.25--
Upgrade
Revenue
1,026785.52633.73505.04537.05520.8
Upgrade
Revenue Growth (YoY)
40.59%23.95%25.48%-5.96%3.12%19.35%
Upgrade
Cost of Revenue
610.06519.53409.39319.61306.74307.12
Upgrade
Gross Profit
415.8265.99224.35185.43230.3213.68
Upgrade
Selling, General & Admin
114.9998.1698.8381.0281.7873.06
Upgrade
Other Operating Expenses
49.8449.7328.4413.6426.3323.34
Upgrade
Operating Expenses
164.83147.89127.2794.66108.1196.39
Upgrade
Operating Income
250.97118.197.0890.77122.2117.29
Upgrade
Interest Expense
-46.32-23.09-2.32-0.95-0.04-
Upgrade
Interest & Investment Income
27.7327.981.111.674.41.93
Upgrade
Currency Exchange Gain (Loss)
2.576.249.753.240.090.48
Upgrade
Other Non Operating Income (Expenses)
4.133.171.113.054.29-
Upgrade
EBT Excluding Unusual Items
239.09132.4106.7397.78130.94119.69
Upgrade
Gain (Loss) on Sale of Assets
0.180.18-0.510.01-
Upgrade
Pretax Income
239.27132.58106.7398.3130.96119.69
Upgrade
Income Tax Expense
54.2729.7523.962229.5526.89
Upgrade
Net Income
184.99102.8282.7776.3101.4192.8
Upgrade
Preferred Dividends & Other Adjustments
2.8614.4811.64---
Upgrade
Net Income to Common
182.1388.3571.1376.3101.4192.8
Upgrade
Net Income Growth
99.00%24.23%8.48%-24.76%9.28%115.30%
Upgrade
Shares Outstanding (Basic)
766777
Upgrade
Shares Outstanding (Diluted)
766777
Upgrade
Shares Change (YoY)
26.08%--11.45%-2.11%-6.76%-6.65%
Upgrade
EPS (Basic)
27.0114.7211.8511.2614.6512.50
Upgrade
EPS (Diluted)
27.0114.7211.8511.2614.6512.50
Upgrade
EPS Growth
107.27%24.21%5.28%-23.14%17.20%130.63%
Upgrade
Free Cash Flow
27.38-83.1924.33-57.047.7170.7
Upgrade
Free Cash Flow Per Share
4.06-13.864.05-8.421.119.52
Upgrade
Dividend Per Share
8.3508.3504.5004.8005.0002.500
Upgrade
Dividend Growth
85.56%85.56%-6.25%-4.00%100.00%-19.36%
Upgrade
Gross Margin
40.53%33.86%35.40%36.72%42.88%41.03%
Upgrade
Operating Margin
24.46%15.04%15.32%17.97%22.75%22.52%
Upgrade
Profit Margin
17.75%11.25%11.22%15.11%18.88%17.82%
Upgrade
Free Cash Flow Margin
2.67%-10.59%3.84%-11.29%1.44%13.58%
Upgrade
EBITDA
273.19128.1399.46100.17130.01118.02
Upgrade
EBITDA Margin
26.63%16.31%15.69%19.83%24.21%22.66%
Upgrade
D&A For EBITDA
22.2210.032.389.397.810.73
Upgrade
EBIT
250.97118.197.0890.77122.2117.29
Upgrade
EBIT Margin
24.46%15.04%15.32%17.97%22.75%22.52%
Upgrade
Effective Tax Rate
22.68%22.44%22.45%22.38%22.56%22.47%
Upgrade
Revenue as Reported
1,026785.52633.73505.04537.05521.07
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.